Adaptative capacity of mitochondrial biogenesis and of mitochondrial dynamics in response to pathogenic respiratory chain dysfunction

Antioxidants and Redox Signaling

Volumn 19, Issue 4, 2013, Pages 350-365

  Benard, Giovanni ^a   Trian, Thomas ^a,b   Bellance, Nadège ^a   Berger, Patrick ^a,b,c   Lavie, Julie ^a   Espil Taris, Caroline ^c   Rocher, Christophe ^a,d   Eimer Bouillot, Sandrine ^c   Goizet, Cyril ^a,c   Nouette Gaulain, Karine ^a,c   Letellier, Thierry ^a,d   Lacombe, Didier ^a,c   Rossignol, Rodrigue ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DPR1 PROTEIN; MESSENGER RNA; MITOCHONDRIAL PROTEIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ADAPTATION; ADOLESCENT; ADULT; ARTICLE; BIOGENESIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL DYNAMICS; MUSCLE BIOPSY; MUTANT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; SCHOOL CHILD; SKIN FIBROBLAST;

BLOTTING, WESTERN; CELLS, CULTURED; ELECTRON TRANSPORT; FIBROBLASTS; HUMANS; MICROSCOPY, ELECTRON; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; NITRIC OXIDE; POTASSIUM CYANIDE; REACTIVE OXYGEN SPECIES;

EID: 84879872504     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4244     Document Type: Article

References (61)

1. Arnould T, Vankoningsloo S, Renard P, Houbion A, Ninane N, Demazy C, Remacle J, and Raes M. CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. EMBO J 21: 53-63, 2002. (Pubitemid 34087074)
2. Benard G, Bellance N, James D, Parrone P, Fernandez H, Letellier T, and Rossignol R. Mitochondrial bioenergetics and structural network organization. J Cell Sci 120: 838-848, 2007. (Pubitemid 46523485)
3. Benard G, Bellance N, Jose C, and Rossignol R. Relationships Between Mitochondrial Dynamics and Bioenergetics. In: Mitochondrial Dynamics and Neurodegeneration. edited by Lu B. Dordrecht: Springer; 2011.
4. Benard G, Faustin B, Galinier A, Rocher C, Bellance N, Smolkova K, Casteilla L, Rossignol R, and Letellier T. Functional dynamic compartmentalization of respiratory chain intermediate substrates: Implications for the control of energy production and mitochondrial diseases. Int J Biochem Cell Biol 40: 1543-1554, 2008.
5. Benard G, Faustin B, Passerieux E, Galinier A, Rocher C, Bellance N, Delage JP, Casteilla L, Letellier T, and Rossignol R. Physiological diversity of mitochondrial oxidative phosphorylation. Am J Physiol Cell Physiol 291: C1172-1182, 2006. (Pubitemid 44878587)
6. Canto C and Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol 20: 98-105, 2009.
7. Cao W, Daniel KW, Robidoux J, Puigserver P, Medvedev AV, Bai X, Floering LM, Spiegelman BM, and Collins S. p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene. Mol Cell Biol 24: 3057-3067, 2004. (Pubitemid 38381292)
8. Cipolat S, Rudka T, Hartmann D, Costa V, Serneels L, Craessaerts K, Metzger K, Frezza C, Annaert W, D'Adamio L, Derks C, Dejaegere T, Pellegrini L, D'Hooge R, Scorrano L, and De Strooper B. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126: 163-175, 2006.
9. Clementi E and Nisoli E. Nitric oxide and mitochondrial biogenesis: A key to long-term regulation of cellular metabolism. Comp Biochem Physiol A Mol Integr Physiol 142: 102-110, 2005. (Pubitemid 41443568)
10. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, and Griffin JL. Mitochondrial myopathy caused by longterm zidovudine therapy. N Engl J Med 322: 1098-1105, 1990. (Pubitemid 20149526)
11. Durrieu G, Letellier T, Antoch J, Deshouillers J, Malgat M, and Mazat J. Identification of mitochondrial deficiency using principal component analysis.Mol Cell Biochem 174: 149-156, 1997. (Pubitemid 27404183)
12. Duvezin-Caubet S, Jagasia R, Wagener J, Hofmann S, Trifunovic A, Hansson A, Chomyn A, Bauer MF, Attardi G, Larsson NG, Neupert W, and Reichert AS. Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J Biol Chem 281: 37972-37979, 2006. (Pubitemid 46042101)
13. Elachouri G, Vidoni S, Zanna C, Pattyn A, Boukhaddaoui H, Gaget K, Yu-Wai-Man P, Gasparre G, Sarzi E, Delettre C, Olichon A, Loiseau D, Reynier P, Chinnery PF, Rotig A, Carelli V, Hamel CP, Rugolo M, and Lenaers G. OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res 21: 12-20, 2011.
14. Faustin B, Rossignol R, Rocher C, Benard G, Malgat M, and Letellier T. Mobilization of adenine nucleotide translocators as molecular bases of the biochemical threshold effect observed in mitochondrial diseases. J Biol Chem 279: 20411-20421, 2004. (Pubitemid 38623488)
15. Franko A, Mayer S, Thiel G, Mercy L, Arnould T, Hornig-Do HT, Wiesner RJ, and Goffart S. CREB-1alpha is recruited to and mediates upregulation of the cytochrome c promoter during enhanced mitochondrial biogenesis accompanying skeletal muscle differentiation. Mol Cell Biol 28: 2446-2459, 2008. (Pubitemid 351429988)
16. Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, Bartoli D, Polishuck RS, Danial NN, De Strooper B, and Scorrano L. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126: 177-189, 2006.
17. Gianotti TF, Sookoian S, Dieuzeide G, Garcia SI, Gemma C, Gonzalez CD, and Pirola CJ. A decreased mitochondrial DNA content is related to insulin resistance in adolescents. Obesity 16: 1591-1595, 2008. (Pubitemid 351915123)
18. Graham BH, Waymire KG, Cottrell B, Trounce IA, Mac-Gregor GR, and Wallace DC. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet 16: 226-234, 1997. (Pubitemid 27280204)
19. Hansson A, Hance N, Dufour E, Rantanen A, Hultenby K, Clayton DA, Wibom R, and Larsson NG. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci USA 101: 3136-3141, 2004. (Pubitemid 38327747)
20. Heinrich R and Rapoport T. Linear theory of enzymatic chain: Its application for analysis of the crossover theorem and of the glycolisis of human erytrocyte. Acta Biol Med Germ 31: 479-494, 1973.
21. Heinrich R and Rapoport T. Mathematical anlysis of multienzyme systems. III. Steady-state and transient control. Biosystems 7: 130-136, 1975.
22. Heinrich R and Rapoport TA. A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. Eur J Biochem 42: 89-95, 1974.
23. Hood DA, Irrcher I, Ljubicic V, and Joseph AM. Coordination of metabolic plasticity in skeletal muscle. J Exp Biol 209: 2265-2275, 2006. (Pubitemid 44065521)
24. Jeffree RL, Wills EJ, and Harper C. An unusual myopathy: Speckled muscle fibers due to enlarged mitochondria. Muscle Nerve 36: 118-122, 2007. (Pubitemid 47016172)
25. Kacser H. The control of enzyme systems in vivo: Elasticity analysis of the steady state. Biochem Soc Trans 11: 35-40, 1983.
26. Kacser H and Burns JA. The control of flux. Symp Soc Exp Biol 27: 65-104, 1973.
27. Kacser H and Porteous J. Control of metabolism: What do we have to measure? Trends Biochem Sci 12: 5-14, 1987.
28. Karbowski M, Arnoult D, Chen H, Chan DC, Smith CL, and Youle RJ. Quantitation of mitochondrial dynamics by photolabeling of individual organelles shows that mitochondrial fusion is blocked during the Bax activation phase of apoptosis. J Cell Biol 164: 493-499, 2004. (Pubitemid 38233310)
29. Karbowski M, Neutzner A, and Youle RJ. The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1-dependent mitochondrial division. J Cell Biol 178: 71-84, 2007. (Pubitemid 47026403)
30. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, and Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122, 2006. (Pubitemid 44894520)
31. Lee YJ, Jeong SY, Karbowski M, Smith CL, and Youle RJ. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 15: 5001-5011, 2004. (Pubitemid 39392214)
32. Letellier T, Durrieu G, Malgat M, Rossignol R, Antoch J, Deshouillers JM, Coquet M, Lacombe D, Netter JC, Pedespan JM, Redonnet-Vernhet I, and Mazat JP. Statistical analysis of mitochondrial pathologies in childhood: Identification of deficiencies using principal component analysis. Lab Invest 80: 1019-1030, 2000. (Pubitemid 30483220)
33. Letellier T, Heinrich R, Malgat M, and Mazat JP. The kinetic basis of threshold effects observed in mitochondrial diseases: A systemic approach. Biochem J 302: 171-174, 1994. (Pubitemid 24256350)
34. Letellier T, Malgat M, Coquet M, Moretto B, Parrot-Roulaud F, and Mazat JP. Mitochondrial myopathy studies on permeabilized muscle fibers. Pediatr Res 32: 17-22, 1992.
35. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, and Spiegelman BM. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797-801, 2002.
36. Lombes A, Mendell JR, Nakase H, Barohn RJ, Bonilla E, Zeviani M, Yates AJ, Omerza J, Gales TL, and Nakahara K, et al. Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: Neuropathology, biochemistry, and molecular genetics. Ann Neurol 26: 20-33, 1989. (Pubitemid 19190039)
37. Mercy L, Pauw A, Payen L, Tejerina S, Houbion A, Demazy C, Raes M, Renard P, and Arnould T. Mitochondrial biogenesis in mtDNA-depleted cells involves a Ca2 + -dependent pathway and a reduced mitochondrial protein import. FEBS J 272: 5031-5055, 2005. (Pubitemid 41415125)
38. Michel S, Wanet A, De Pauw A, Rommelaere G, Arnould T, and Renard P. Crosstalk between mitochondrial (dys)function and mitochondrial abundance. J Cell Physiol 227: 2297-2310, 2012.
39. Moncada S and Bolanos JP. Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 97: 1676-1689, 2006. (Pubitemid 43873660)
40. Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, Nakase H, Bonilla E, Werneck LC, Servidei S, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 320: 1293-1299, 1989. (Pubitemid 19140403)
41. Moraes CT, Sciacco M, Ricci E, Tengan CH, Hao H, Bonilla E, Schon EA, and DiMauro S. Phenotype-genotype correlations in skeletal muscle of patients with mtDNA deletions. Muscle Nerve 3: S150-153, 1995.
42. Niwano K, Arai M, Koitabashi N, Hara S, Watanabe A, Sekiguchi K, Tanaka T, Iso T, and Kurabayashi M. Competitive binding of CREB and ATF2 to cAMP/ATF responsive element regulates eNOS gene expression in endothelial cells. Arterioscler Thromb Vasc Biol 26: 1036-1042, 2006. (Pubitemid 43732109)
43. Perry CG, Lally J, Holloway GP, Heigenhauser GJ, Bonen A, and Spriet LL. Repeated transient mRNA bursts precede increases in transcriptional and mitochondrial proteins during training in human skeletal muscle. J Physiol 588: 4795-4810, 2010.
44. Rossignol R, Faustin B, Rocher C, Malgat M, Mazat JP, and Letellier T. Mitochondrial threshold effects. Biochem J 370: 751-762, 2003. (Pubitemid 36399067)
45. Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington SJ, and Capaldi RA. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res 64: 985-993, 2004. (Pubitemid 38176901)
46. Rossignol R, Malgat M, Mazat J-P, and Letellier T. Threshold effect and tissue specificity. J Biol Chem 274: 33426-33432, 1999.
47. Rossignol R, Malgat M, Mazat JP, and Letellier T. Threshold effect and tissue specificity. Implication for mitochondrial cytopathies. J Biol Chem 274: 33426-33432, 1999. (Pubitemid 129511648)
48. Schon EA and DiMauro S. Mitochondrial mutations: Genotype to phenotype. Novartis Found Symp 287: 214-233, 2007.
49. Shoubridge EA, Karpati G, and Hastings KE. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease. Cell 62: 43-49, 1990.
50. Smirnova E, Shurland DL, Ryazantsev SN, and van der Bliek AM. A human dynamin-related protein controls the distribution of mitochondria. J Cell Biol 143: 351-358, 1998. (Pubitemid 28487855)
51. Soriano FX, Liesa M, Bach D, Chan DC, Palacin M, and Zorzano A. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin Diabetes 55: 1783-1791, 2006. (Pubitemid 44324133)
52. Srivastava S, Diaz F, Iommarini L, Aure K, Lombes A, and Moraes CT. PGC-1{alpha}/{beta} induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders. Hum Mol Genet 18: 1805-1812, 2009.
53. Trian T, Benard G, Begueret H, Rossignol R, Girodet PO, Ghosh D, Ousova O, Vernejoux JM, Marthan R, Tunon-de-Lara JM, and Berger P. Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma. J Exp Med 204: 3173-3181, 2007.
54. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly YM, Gidlof S, Oldfors A, Wibom R, Tornell J, Jacobs HT, and Larsson NG. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417-423, 2004. (Pubitemid 38715133)
55. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, and Shirihai OS. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27: 433-446, 2008. (Pubitemid 351161653)
56. Vankoningsloo S, De Pauw A, Houbion A, Tejerina S, Demazy C, de Longueville F, Bertholet V, Renard P, Remacle J, Holvoet P, Raes M, and Arnould T. CREB activation induced by mitochondrial dysfunction triggers triglyceride accumulation in 3T3-L1 preadipocytes. J Cell Sci 119: 1266-1282, 2006.
57. Vankoningsloo S, Piens M, Lecocq C, Gilson A, De Pauw A, Renard P, Demazy C, Houbion A, Raes M, and Arnould T. Mitochondrial dysfunction induces triglyceride accumulation in 3T3-L1 cells: Role of fatty acid beta-oxidation and glucose. J Lipid Res 46: 1133-1149, 2005. (Pubitemid 43109829)
58. Villani G and Attardi G. In vivo control of respiration by cytochrome c oxidase in wild-type and mitochondrial DNA mutation-carrying human cells. Proc Natl Acad Sci USA 94: 1166-1171, 1997. (Pubitemid 27087822)
59. Wenz T, Diaz F, Spiegelman BM, and Moraes CT. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab 8: 249-256, 2008.
60. Wredenberg A, Wibom R, Wilhelmsson H, Graff C, Wiener HH, Burden SJ, Oldfors A, Westerblad H, and Larsson NG. Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci USA 99: 15066-15071, 2002. (Pubitemid 35334610)
61. Wu Z, Huang X, Feng Y, Handschin C, Gullicksen PS, Bare O, Labow M, Spiegelman B, and Stevenson SC. Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells. Proc Natl Acad Sci USA 103: 14379-14384, 2006. (Pubitemid 44484758) Médicale